Pimobendan API
A Proven Positive Inotropic and Vasodilatory Agent for Canine Heart Failure
Product Overview
Pimobendan API is an active pharmaceutical ingredient widely used in veterinary cardiology, especially for the treatment of heart failure in dogs . It is classified as a positive inotropic and vasodilatory agent, designed to improve cardiac performance and enhance the overall quality of life in dogs suffering from heart disease.
Product Name: Pimobendan API
CAS Number: 74150-27-9
Quality Standard: In-House / IP / EP / BP
Category: Veterinary Active Pharmaceutical Ingredient (API)
Mechanism of Action
Pimobendan operates through a unique dual mechanism that targets both cardiac output and vascular resistance simultaneously:
▸ Positive inotropic action - increases the strength of heart muscle contractions
▸ Vasodilatory action - dilates blood vessels to improve blood flow
▸ Reduces the overall workload and pressure on the heart
▸ Supports more efficient circulation throughout the body
This dual mechanism makes Pimobendan one of the most effective therapeutic options for managing canine congestive heart failure.
Veterinary Applications of Pimobendan
1.Canine Congestive Heart Failure
Pimobendan has been used in canine heart failure management since its FDA approval in 2007. It is commonly prescribed for dogs with congestive heart failure caused by:
▸ Dilated cardiomyopathy
▸ Degenerative mitral valve disease
▸ Other conditions resulting in reduced cardiac output
By improving the heart's pumping efficiency, it helps relieve cardiac pressure and supports better systemic circulation.
2. Improvement of Clinical Symptoms
Clinical studies and long-term veterinary use have shown that dogs receiving Pimobendan experience noticeable improvements in:
▸ Energy levels and vitality
▸ Breathing comfort and respiratory ease
▸Appetite and exercise tolerance
In many cases, the medication also helps extend lifespan while maintaining a better quality of daily life.
3. Safety and Long-Term Tolerability
Pimobendan is well known for its high safety profile and good tolerability in dogs of all ages and breeds. When used under proper veterinary supervision:
▸ Reported side effects are rare, mild, and generally temporary
▸ Dosage adjustments can manage any gastrointestinal discomfort
▸ Suitable for long-term therapeutic use with regular monitoring
Pimobendan must be administered only under veterinary supervision to ensure optimal therapeutic outcomes and minimize potential risks.
Benefits of Pimobendan API
▸ Improves heart contractility and cardiac output
▸ Reduces cardiac workload through vasodilation
▸ Enhances energy levels and exercise tolerance
▸ Helps relieve symptoms of congestive heart failure
▸ Proven to improve quality of life and extend lifespan
▸ Safe and suitable for long-term veterinary use
Our Manufacturing Strengths
Complete Manufacturing System
Our manufacturing facility covers a total area of 2,523 m² , including 365 m² of Class D clean areas . The workshop is designed and operated in full compliance with GMP requirements to ensure consistent and reliable API production.
Strict Quality Control
We enforce strict quality control at every stage of production, including:
▸ Raw material inspection and qualification
▸ Environmental monitoring throughout manufacturing
▸ Final product testing for high purity, safety, and consistency
Excellent Customer Service
Customer satisfaction is our continuous pursuit. We are committed to understanding customer needs and providing comprehensive technical, regulatory, and commercial support tailored to each client.
Frequently Asked Questions
Q1: What application fields do your products cover?
Our products are widely used in reproduction, endocrinology, and gynecology for both human and veterinary applications.
Q2: Can customers visit your factory for quality audits?
Yes. Customers are welcome to visit our factory for audits when required. Please contact us in advance to schedule an appointment - we are always ready to support you.
Conclusion
Pimobendan API Pharmaceutical Grade (CAS 74150-27-9) is a highly effective and trusted treatment for canine heart failure. Its unique dual mechanism of positive inotropic and vasodilatory action, combined with a strong long-term safety profile, makes it an indispensable API in modern veterinary cardiology. When administered under proper veterinary supervision, Pimobendan delivers meaningful improvements in cardiac function, symptom relief, and overall quality of life for affected dogs.
Hot Tags: Pimobendan API 74150-27-9, China Pimobendan API 74150-27-9 manufacturers, suppliers, factory, small molecular products for veterinary drug discovery, small molecular substances for veterinary drug discovery, animal treatment small molecular substances for drug discovery, Pradofloxacin CAS 195532 12 8, compounds for veterinary drug screening, veterinary small molecular compounds for new drug development









